Gorlia, T: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma

Hegi, Monika E., Diserens, Annie-Claire, Gorlia, Thierry, Hamou, Marie-France, de Tribolet, Nicolas, Weller, Michael, Kros, Johan M., Hainfellner, Johannes A., Mason, Warren, Mariani, Luigi, Bromberg,

Journal:

Boston Medical and Surgical Journal

Year:

2005

Language:

english

File:

PDF, 107 KB

english, 2005

2

Radiotherapy (RT) and concomitant and adjuvant temozolomide (TMZ) versus radiotherapy alone for newly diagnosed glioblastoma (GBM): Overall results and recursive partitioning analysis (RPA) of a phase III randomized trial of the EORTC brain tumor and radiotherapy groups and the NCIC clinical trial group

R. Mirimanoff, W. Mason, R. Kortmann, M. Van den Bent, B. Fisher, M. Taphoorn, M. Reni, J. Curschmann, S. Villa, G. Cairncross, T. Gorlia, R. Stupp

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2004

Language:

english

File:

PDF, 22 KB

english, 2004

3

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

MJ van den Bent, JS Wefel, D Schiff, MJB Taphoorn, K Jaeckle, L Junck, T Armstrong, A Choucair, AD Waldman, T Gorlia, M Chamberlain, BG Baumert, MA Vogelbaum, DR Macdonald, DA Reardon, PY Wen, SM Chan

Journal:

The Lancet Oncology

Year:

2011

Language:

english

File:

PDF, 452 KB

english, 2011

4

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

Vermorken, Jan B., Remenar, Eva, van Herpen, Carla, Gorlia, Thierry, Mesia, Ricard, Degardin, Marian, Stewart, John S., Jelic, Svetislav, Betka, Jan, Preiss, Joachim H., van den Weyngaert, Danielle, A

Journal:

Boston Medical and Surgical Journal

Year:

2007

Language:

english

File:

PDF, 210 KB

english, 2007

5

Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors : A translational research project of the European Organization for Research and Treatment of Cancer Rrain Tumor Group

Matthias Preusser, Harald Heinzl, Ellen Gelpi, Katharina Schonegger, Christine Haberler, Peter Birner, Christine Marosi, Monika Hegi, Thierry Gorlia, Johannes A. Hainfellner

Journal:

Year:

2006

Language:

english

File:

PDF, 311 KB

english, 2006

6

Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme : A report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study

Leida M. Lamers, Roger Stupp, Martin J. van den Bent, Maiwenn J. Al, Thierry Gorlia, Jean-Blaise Wasserfallen, Nicole Mittmann, Soo Jin Seung, Ralph Crott, Carin A. Uyl-de Groot

Journal:

Year:

2008

Language:

english

File:

PDF, 194 KB

english, 2008

7

Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy : European organization for research and treatment of cancer trial 26951

Karima Mokhtari, François Ducray, Johan M. Kros, Thierry Gorlia, Ahmed Idbaih, Martin Taphoorn, Pieter Wesseling, Khe Hoang-Xuan, Martin Van den Bent, Marc Sanson

Journal:

Year:

2011

Language:

english

File:

PDF, 549 KB

english, 2011

8

Estimating survival gain for economic evaluations with survival time as principal endpoint: A cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer

N. Neymark, I. Adriaenssen, T. Gorlia, S. Caleo, M. Bolla

Journal:

Health Economics

Year:

2002

Language:

english

File:

PDF, 240 KB

english, 2002

9

Is Long-Term Survival in Glioblastoma Possible? Updated Results of the EORTC/NCIC Phase III Randomized Trial on Radiotherapy (RT) and Concomitant and Adjuvant Temozolomide (TMZ) versus RT Alone

R. Mirimanoff, W. Mason, M. Van den Bent, R. Kortmann, M. Taphoorn, A. Brandes, S. Villa, G. Cairncrosss, T. Gorlia, R. Stupp

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2007

Language:

english

File:

PDF, 46 KB

english, 2007

10

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951

Ahmed Idbaih, Cyril Dalmasso, Mathilde Kouwenhoven, Judith Jeuken, Catherine Carpentier, Thierry Gorlia, Johan M. Kros, Pim French, Johannes Teepen, Philippe Broët, Olivier Delattre, Karima Mokhtari,

Journal:

Journal of Neuro-Oncology

Year:

2011

Language:

english

File:

PDF, 340 KB

english, 2011

11

Chemoradiotherapy of Newly Diagnosed Glioblastoma With Intensified Temozolomide

Markus Weiler, Christian Hartmann, Dorothee Wiewrodt, Ulrich Herrlinger, Thierry Gorlia, Oliver Bähr, Richard Meyermann, Michael Bamberg, Marcos Tatagiba, Andreas von Deimling, Michael Weller, Wolfgan

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2010

Language:

english

File:

PDF, 140 KB

english, 2010

12

Prognostic value of Ki67 index in anaplastic oligodendroglial tumours – a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group

Matthias Preusser, Romana Hoeftberger, Adelheid Woehrer, Ellen Gelpi, Mathilde Kouwenhoven, Johan M Kros, Marc Sanson, Ahmed Idbaih, Alba A Brandes, Harald Heinzl, Thierry Gorlia, Johannes A Hainfelln

Journal:

Year:

2012

Language:

english

File:

PDF, 428 KB

english, 2012

13

Chromosome 1p loss evaluation in anaplastic oligodendrogliomas

Ahmed Idbaih, Mathilde Kouwenhoven, Judith Jeuken, Catherine Carpentier, Thierry Gorlia, Johan M. Kros, Pim French, Johannes L. Teepen, Olivier Delattre, Jean-Yves Delattre, Martin Van Den Bent, Khê H

Journal:

Year:

2008

Language:

english

File:

PDF, 177 KB

english, 2008

14

Anti-O6-Methylguanine-Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker

Matthias Preusser, Robert Charles Janzer, Jörg Felsberg, Guido Reifenberger, Marie-France Hamou, Annie-Claire Diserens, Roger Stupp, Thierry Gorlia, Christine Marosi, Harald Heinzl, Johannes A Hainfel

Journal:

Brain Pathology

Year:

2008

Language:

english

File:

PDF, 629 KB

english, 2008

15

Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial

Monika E. Hegi, Robert-Charles Janzer, Wanyu L. Lambiv, Thierry Gorlia, Mathilde C. M. Kouwenhoven, Christian Hartmann, Andreas von Deimling, Danielle Martinet, Nathalie Besuchet Schmutz, Annie-Claire

Journal:

Acta Neuropathologica

Year:

2012

Language:

english

File:

PDF, 829 KB

english, 2012

16

Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: An assessment of clinical potential

J.W. Hopewell, T. Gorlia, L. Pellettieri, V. Giusti, B. H-Stenstam, K. Sköld

Journal:

Applied Radiation and Isotopes

Year:

2011

Language:

english

File:

PDF, 341 KB

english, 2011

17

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, Wolfgang Hoeltl, Fernando Calais Da Silva, Philip H. Powell, Stephen Prescott, Ziya Kirkali, Cees van de Beek, Thierry Gorlia, Theo M. de Reij

Journal:

European Urology

Year:

2010

Language:

english

File:

PDF, 408 KB

english, 2010

18

RNOP-09: Pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma - a phase II study

Christoph P Beier, Christina Schmid, Thierry Gorlia, Christine Kleinletzenberger, Dagmar Beier, Oliver Grauer, Andreas Steinbrecher, Birgit Hirschmann, Alexander Brawanski, Christopher Dietmaier, Tanj

Journal:

Year:

2009

Language:

english

File:

PDF, 274 KB

english, 2009

19

Radiothérapie avec ou sans témozolomide dans les glioblastomes : résultats actualisés de l’étude de phase III randomisée de l’EORTC/NCI-C

R.O. Mirimanoff, W. Mason, M.J. Van Den Bent, R. Kortmann, M. Taphoorn, A.A. Brandes, J.G. Cairncross, T. Gorlia, M. Hegi, R. Stupp

Journal:

Cancer/Radiothérapie

Year:

2008

Language:

french

File:

PDF, 57 KB

french, 2008

20

Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: An EORTC phase III study (10863)

L. Beex, C. Rose, H. Mouridsen, J. Jassem, M. Nooij, J. Estape, R. Paridaens, M. Piccart, T. Gorlia, S. Lardenoije, L. Baila

Journal:

European Journal of Cancer

Year:

2006

Language:

english

File:

PDF, 230 KB

english, 2006

21

Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: Results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882)

Jerzy Hildebrand, Thierry Gorlia, Johan M. Kros, Dénes Afra, Marc Frenay, Antonio Omuro, Roger Stupp, Denis Lacombe, Anouk Allgeier, Martin J. van den Bent

Journal:

European Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 279 KB

english, 2008

22

EORTC study 26041-22041: Phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma

Alba A. Brandes, Roger Stupp, Peter Hau, Denis Lacombe, Thierry Gorlia, Alicia Tosoni, Renè O. Mirimanoff, Johan M. Kros, Martin J. van den Bent

Journal:

European Journal of Cancer

Year:

2010

Language:

english

File:

PDF, 294 KB

english, 2010

23

Appropriate end-points for right results in the age of antiangiogenic agents: Future options for phase II trials in patients with recurrent glioblastoma

A.A. Brandes, E. Franceschi, T. Gorlia, W. Wick, A.H. Jacobs, B.G. Baumert, M. van den Bent, M. Weller, R. Stupp

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 464 KB

english, 2012

24

New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials

Thierry Gorlia, Roger Stupp, Alba A. Brandes, Roy R. Rampling, Pierre Fumoleau, Christian Dittrich, Mario M. Campone, Chris C. Twelves, Eric Raymond, Monika E. Hegi, Denis Lacombe, Martin J. van den B

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 216 KB

english, 2012

25

Chronothérapeutique des cancers : optimisation du schéma d'administration différente selon le sexe

F. Lévi, T. Gorlia, S. Giacchetti, G. Bjarnason, C. Garufi, M.-A. Lentz, S. Marreaud, C. Focan

Journal:

Pathologie Biologie

Year:

2007

File:

PDF, 53 KB

2007

26

Cost-effectiveness of the addition of early hormonal therapy in locally advanced prostate cancer: results decisively determined by the cut-off time-point chosen for the analysis

N Neymark, I Adriaenssen, T Gorlia, S Caleo, M Bolla, D Brochon

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 160 KB

english, 2001

27

Statistical methodology of phase III cancer clinical trials: advances and future perspectives

R Sylvester, M Van Glabbeke, L Collette, S Suciu, B Baron, C Legrand, T Gorlia, G Collins, C Coens, L Declerck, P Therasse

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 108 KB

english, 2002

28

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma

Franceschi, E., Stupp, R., van den Bent, M. J., van Herpen, C., Laigle Donadey, F., Gorlia, T., Hegi, M., Lhermitte, B., Strauss, L. C., Allgeier, A., Lacombe, D., Brandes, A. A.

Journal:

Year:

2012

Language:

english

File:

PDF, 148 KB

english, 2012

29

CN2 COST-EFFECTIVENESS OFTEMOZOLOMIDE FORTHE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME IN THE UK

CA Uyl-de Groot, LM Lamers, M Al, M Bent van den, T Gorlia, R Crott, W Mason, R Stupp

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 56 KB

english, 2005

30

31 Temozolomide (TMZ) targets only glioblastoma with a silenced MGMT-gene. Results of a translational companion study to EORTC 26981/NCIC CE.3 of radiotherapy ± TMZ

M. Hegi, A. Diserens, M. Hamou, T. Gorlia, M. Weller, J. Kros, J. Hainfellner, U. Bogdahn, G. Cairncross, R. Stupp

Journal:

European Journal of Cancer Supplements

Year:

2004

Language:

english

File:

PDF, 138 KB

english, 2004

31

Intermittent/alternated therapy with tamoxifen and medroxy-progesterone acetate prolongs time to resistance to tamoxifen without benefit for (progression free) survival in patients with advanced breast cancer. Results of an EORTC phase III study (trial 10863)

L Beex, C Rose, H Mouridsen, J Jassem, M Nooy, J Estape, R Paridaens, M.J Piccart, T Gorlia, L Baila

Journal:

European Journal of Cancer Supplements

Year:

2004

Language:

english

File:

PDF, 172 KB

english, 2004

32

114 INVITED Malignant glioma: molecular pathways, mechanisms of disease and resistance to chemoradiotherapy

M.E. Hegi, E. Migliavacca, T. Gorlia, W.L. Lambiv, T. Shay, E. Domany, M. Delorenzi, R. Stupp, A. Murat

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 81 KB

english, 2007

33

2503 ORAL Erlotinib (E) versus temozolomide (TMZ) or BCNU in recurrent glioblastoma multiforme (GBM): results from a randomized phase II trial (EORTC 26034)

M.J. van den Bent, A.A. Brandes, R. Rampling, M. Kouwenhoven, J. Kros, A. Carpentier, P. Clement, B. Klughammer, D. Lacombe, T. Gorlia

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 62 KB

english, 2007

34

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

Thierry Gorlia, Martin J van den Bent, Monika E Hegi, René O Mirimanoff, Michael Weller, J Gregory Cairncross, Elizabeth Eisenhauer, Karl Belanger, Alba A Brandes, Anouk Allgeier, Denis Lacombe, Roger

Journal:

The Lancet Oncology

Year:

2008

Language:

english

File:

PDF, 231 KB

english, 2008

35

EORTC topics in neurooncology: The long path from a focus on neurological complications of cancer towards molecularly defined trials and therapies in neurooncology

Wolfgang Wick, Martin van den Bent, Charles Vecht, Alba Brandes, Denis Lacombe, Thierry Gorlia, Anouk Allgeier, Brigitta G. Baumert, Riccardo Soffietti, Marc Sanson, Abul B.M.F. Karim, Réne-Olivier Mi

Journal:

European Journal of Cancer Supplements

Year:

2012

Language:

english

File:

PDF, 197 KB

english, 2012

36

Statistical methodology for personalized medicine: New developments at EORTC Headquarters since the turn of the 21st Century

L. Collette, J. Bogaerts, S. Suciu, C. Fortpied, T. Gorlia, C. Coens, M. Mauer, B. Hasan, S. Collette, M. Ouali, S. Litière, J. Rapion, R. Sylvester

Journal:

European Journal of Cancer Supplements

Year:

2012

Language:

english

File:

PDF, 1.24 MB

english, 2012

37

PROGNOSTIC FACTORS IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE TA T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE EPIRUBICIN OR MAINTENANCE BACILLUS CALMETTE-GUERIN. RESULTS OF EORTC GU GROUP STUDY 30911

R.J. Sylvester, W. Oosterlinck, M.A. Brausi, W.J. Kirkels, F. Calais Da Silva, T. Gorlia, Z. Kirkali

Journal:

European Urology Supplements

Year:

2008

Language:

english

File:

PDF, 70 KB

english, 2008

38

LONG-TERM EFFICACY RESULTS OF EORTC GU GROUP STUDY 30911 COMPARING EPIRUBICIN, BACILLUS CALMETTEGUERIN (BCG), AND BCG PLUS ISONIAZID IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE TA T1 PAPILLARY CARCINOMA OF THE BLADDER

R.J. Sylvester, M.A. Brausi, W. Hoeltl, P.H. Powell, P. Whelan, T. Gorlia, T.M. De Reijke

Journal:

European Urology Supplements

Year:

2008

Language:

english

File:

PDF, 73 KB

english, 2008

39

New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials

Gorlia, T., Wu, W., Wang, M., Baumert, B. G., Mehta, M., Buckner, J. C., Shaw, E., Brown, P., Stupp, R., Galanis, E., Lacombe, D., van den Bent, M. J.

Journal:

Year:

2013

Language:

english

File:

PDF, 293 KB

english, 2013

40

Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951

Erdem-Eraslan, L., Gravendeel, L. A., de Rooi, J., Eilers, P. H. C., Idbaih, A., Spliet, W. G. M., den Dunnen, W. F. A., Teepen, J. L., Wesseling, P., Sillevis Smitt, P. A. E., Kros, J. M., Gorlia, T.

Journal:

Journal of Clinical Oncology

Year:

2013

Language:

english

File:

PDF, 191 KB

english, 2013

41

Allowed and forbidden transitions in highly ionized neon-like atoms (Ni XIX-U LXXXIII)

Quinet, P, Gorlia, T, Biémont, E

Journal:

Physica Scripta

Year:

1991

Language:

english

File:

PDF, 1.47 MB

english, 1991

42

LONG-TERM EFFICACY RESULTS OF EORTC GU GROUP STUDY 30911 COMPARING EPIRUBICIN, BACILLUS CALMETTE- GUERIN (BCG), AND BCG PLUS ISONIAZID IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE Ta T1 BLADDER CARCINOMA

Sylvester, Richard, Brausi, Maurizio, Hoeltl, Wolfgang, Powell, Philip, Whelan, Peter, Gorlia, Thierry, De Reijke, Theo

Journal:

The Journal of Urology

Year:

2008

Language:

english

File:

PDF, 138 KB

english, 2008

43

PROGNOSTIC FACTORS IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE Ta T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE EPIRUBICIN OR MAINTENANCE BACILLUS CALMETTE-GUERIN. RESULTS OF EORTC GU GROUP STUDY 30911

Sylvester, Richard, Oosterlinck, Willem, Brausi, Maurizio, Kirkels, Wim J, Da Silva, Fernando Calais, Gorlia, Thierry, Kirkali, Ziya

Journal:

The Journal of Urology

Year:

2008

Language:

english

File:

PDF, 146 KB

english, 2008

44

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951

Gorlia, Thierry, Delattre, Jean-Yves, Brandes, Alba A., Kros, Johan M., Taphoorn, Martin J.B., Kouwenhoven, Mathilde C.M., Bernsen, H.J.J.A., Frénay, Marc, Tijssen, Cees C., Lacombe, Denis, van den Be

Journal:

European Journal of Cancer

Year:

2013

Language:

english

File:

PDF, 340 KB

english, 2013

45

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Stupp, Roger, Hegi, Monika E, Gorlia, Thierry, Erridge, Sara C, Perry, James, Hong, Yong-Kil, Aldape, Kenneth D, Lhermitte, Benoit, Pietsch, Torsten, Grujicic, Danica, Steinbach, Joachim Peter, Wick,

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 569 KB

english, 2014

46

Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential

Sköld, K, Gorlia, T, Pellettieri, L, Giusti, V, H-Stenstam, B, Hopewell, J W

Journal:

British Journal of Radiology

Year:

2010

Language:

english

File:

PDF, 251 KB

english, 2010

47

Stem Cell-Related "Self-Renewal" Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma

Murat, A., Migliavacca, E., Gorlia, T., Lambiv, W. L., Shay, T., Hamou, M.-F., de Tribolet, N., Regli, L., Wick, W., Kouwenhoven, M. C.M., Hainfellner, J. A., Heppner, F. L., Dietrich, P.-Y., Zimmer,

Journal:

Journal of Clinical Oncology

Year:

2008

Language:

english

File:

PDF, 1.52 MB

english, 2008

48

Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study

Sleijfer, S, Gorlia, T, Lamers, C, Burger, H, Blay, J-Y, Le Cesne, A, Scurr, M, Collin, F, Pandite, L, Marreaud, S, Hohenberger, P

Journal:

British Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 412 KB

english, 2012

49

AT-34 * CONSTRUCTION OF AN INTEGRATED DIAGNOSTIC ALGORITHM CONSISTING OF CONSENSUS HISTOLOGIC AND MOLECULAR PARAMETERS OF TWO EORTC TRIALS ON ANAPLASTIC GLIOMA

Kros, J. M., French, P., van den Bent, M. J., Gorlia, T.

Journal:

Year:

2014

Language:

english

File:

PDF, 26 KB

english, 2014

50

A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951

van den Bent, M. J., Gravendeel, L. A., Gorlia, T., Kros, J. M., Lapre, L., Wesseling, P., Teepen, J. L., Idbaih, A., Sanson, M., Smitt, P. A. E. S., French, P. J.

Journal:

Clinical Cancer Research

Year:

2011

Language:

english

File:

PDF, 1.02 MB

english, 2011

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски